About Bharat Biotech
Bharat Biotech is a company based in Hyderabad (India) founded in 1996 by Suchitra Ella and Krishna Ella. Bharat Biotech has raised $13.74 million across 6 funding rounds from investors including International Finance Corporation, Gates Foundation and CEPI. The company has 1,286 employees as of April 04, 2024. Bharat Biotech has completed 1 acquisition, including Chiron Behring India. Bharat Biotech offers products and services including COVAXIN, ROTAVAC, and Typbar TCV. Bharat Biotech operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
- Headquarter Hyderabad, India
- Employees 1286 as on 04 Apr, 2024
- Founders Suchitra Ella, Krishna Ella
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bharat Biotech International Limited
- Date of Incorporation 15 Feb, 1996
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.74 M (USD)
in 6 rounds
-
Latest Funding Round
Not available
-
Investors
International Finance Corporation
& 4 more
-
Employee Count
1286
as on Apr 04, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bharat Biotech
Bharat Biotech offers a comprehensive portfolio of products and services, including COVAXIN, ROTAVAC, and Typbar TCV.
Vaccine for COVID-19 prevention and protection.
Rotavirus vaccine for preventing childhood diarrhea.
Typhoid conjugate vaccine for long-term immunity.
People of Bharat Biotech
Unlock access to complete
Funding Insights of Bharat Biotech
Bharat Biotech has successfully raised a total of $13.74M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bharat Biotech
Bharat Biotech has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include International Finance Corporation, Gates Foundation and CEPI.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare investments are targeted by this private equity firm.
|
Locked | Locked | Locked | |
|
IFC is focused on private sector development in emerging markets.
|
Locked | Locked | Locked | |
|
Alternative asset management and investment services in India.
|
Locked | Locked | Locked |
Investor details for Bharat Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bharat Biotech
Bharat Biotech has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Chiron Behring India.
Investment portfolio details for Bharat Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Limited information available
|
Locked | Locked | 0 | Locked |
Complete acquisition details for Bharat Biotech
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Bharat Biotech
Detailed financials for Bharat Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bharat Biotech Comparisons
Peer comparison for Bharat Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bharat Biotech
Bharat Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
Detailed competitors of Bharat Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bharat Biotech
Complete news archive for Bharat Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bharat Biotech
Bharat Biotech was founded in 1996 and raised its 1st funding round 9 years after it was founded.
Bharat Biotech is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Ajayreddy Parakala is the current CEO of Bharat Biotech.
Bharat Biotech is a funded company, having raised a total of $13.74M across 6 funding rounds to date.
As of Apr 04, 2024, the latest employee count at Bharat Biotech is 1,286.
Manufacturer of vaccines and bio-therapeutic products. It offers a portfolio of products which includes a broad range of vaccines and therapeutics for Hepatitis B, Polio, Rabies, Typhoid, tetanus, pertussis,, and Haemophilus influenzae type b. It also provide topical medicines for wounds, burns, ulcers, and others.
Bharat Biotech's top competitors include Merck, Roivant Sciences and AbbVie.
Bharat Biotech offers COVAXIN, ROTAVAC, and Typbar TCV.
Bharat Biotech has made 1 acquisition, including Chiron Behring India.
Bharat Biotech has 5 investors. Key investors include International Finance Corporation, Gates Foundation, CEPI, ICICI Venture, and Department of Biotechnology.